recent
year
wit
major
ebola
viru
outbreak
africa
zika
outbreak
brazil
novel
coronaviru
china
virus
rare
confin
origin
locat
thu
creat
challeng
contain
newer
virus
also
lack
avail
approv
treatment
indic
need
broaderspectrum
antivir
highlight
one
molecul
tiloron
dihydrochlorid
tiloron
amixin
lavomax
current
regist
human
use
russia
ukrain
kazakhstan
belaru
armenia
georgia
kyrgyzstan
moldova
turkmenistan
uzbekistan
antivir
influenza
acut
respiratori
viral
infect
viral
hepat
viral
enceph
myeliti
other
immunomodul
medic
also
includ
list
essenti
medicin
russian
feder
vivo
efficaci
studi
date
back
support
possibl
use
broad
array
virus
includ
influenza
viru
influenza
b
viru
herp
simplex
viru
west
nile
viru
mengoviru
semliki
forest
viru
vesicular
stomat
viru
encephalomyocard
viru
recent
recent
demonstr
surviv
mice
infect
ebola
viru
treat
tiloron
result
led
us
broadli
profil
antivir
spectrum
activ
focu
chikungunya
viru
chik
middl
eastern
respiratori
syndrom
coronaviru
merscov
tiloron
dihydrochlorid
purchas
sigmaaldrich
st
loui
mo
tiloron
test
use
niaid
dmid
servic
repres
herpesvirida
bunyavirida
togavirida
arenavirida
flavivirida
picornavirida
poxvirida
hepat
virus
respiratori
virus
virus
fourconcentr
cytopath
effect
cpe
inhibit
assay
perform
confluent
nearconflu
cell
cultur
monolay
dispos
micropl
prepar
cell
maintain
minim
essenti
medium
mem
dulbecco
minim
essenti
medium
dmem
supplement
fetal
bovin
serum
fb
requir
cell
line
antivir
assay
medium
use
fb
reduc
less
supplement
gentamicin
test
compound
prepar
four
final
concentr
micromolar
concentr
five
microwel
use
per
dilut
three
infect
cultur
two
uninfect
toxic
cultur
control
experi
consist
six
microwel
infect
viru
control
six
untreat
cell
control
viru
control
cell
control
well
everi
micropl
parallel
known
activ
drug
test
positivecontrol
drug
use
method
appli
test
compound
posit
control
test
test
run
assay
initi
first
remov
growth
medium
plate
cell
test
compound
appli
volum
well
concentr
viru
normal
cell
cultur
infecti
dose
volum
place
well
design
viru
infect
chik
cell
per
well
multipl
infect
moi
merscov
cell
per
well
moi
chik
compound
ad
cell
prior
infect
rang
intend
pretreat
merscov
compound
ad
cell
min
prior
infect
intend
pretreat
medium
devoid
viru
place
toxic
control
well
cell
control
well
viru
control
well
treat
similarli
viru
plate
incub
maximum
cpe
observ
microscop
viru
control
well
chik
merscov
incub
day
plate
stain
neutral
red
approxim
h
incub
neutral
red
medium
remov
complet
aspir
cell
rins
one
time
phosphatebuff
solut
pb
remov
residu
dye
pb
complet
remov
incorpor
neutral
red
elut
sorensen
citrat
ethanol
least
min
dye
content
well
quantifi
use
spectrophotomet
wavelength
effect
virusinhibitori
concentr
cytotox
cellinhibitori
concentr
calcul
linear
regress
analysi
quotient
divid
give
select
index
valu
ideal
compound
show
valu
consid
activ
identifi
promis
micromolar
activ
tiloron
chik
merscov
reason
select
index
tabl
vitro
activ
merscov
also
agre
recent
find
other
combin
observ
along
earlier
descript
mani
antivir
activ
suggest
tiloron
potenti
broadspectrum
antivir
may
util
addit
coronavirus
drug
approv
russian
feder
countri
tiloron
never
evalu
test
safeti
efficaci
studi
meet
current
ich
fda
guidelin
regul
recent
viru
outbreak
sever
acut
respiratori
syndrom
coronaviru
suggest
urgent
need
reassess
compound
broadspectrum
antivir
yet
fulli
appreci
util
drug
discov
year
ago
